Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric Carboxymaltose for Anemia in Lymphoid Malignancies
NCT01101399Phase 3Completed
- Sponsor
- CSL Vifor
- Start
- May 2010
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by CSL Vifor. Started May 2010; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT01101399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01101399.